Blue Horseshoe Stocks: DAL Options & More

Delta Airlines Inc. DAL

Despite a tumultuous day for the markets yesterday, and mostly everything taking on a bearish characteristic, we’re still going to go bullish on DAL in the wake of the company’s quarterly earnings report released this morning.

Despite rising fuel costs, the company revealed that profits soared well past expectations as a result of increased demand leading to higher ticket prices.

As we always try to do when a company posts a solid beat, we’ll designate a range of options to place on watch, in this case the DAL Weekly $49.50-52 Calls. We’ll go ahead and track these into the end of the week. DAL stock was already oversold, getting hammered for weeks, so this report may be just the catalyst needed to effect an impressive reversal.



SPDR S&P 500 ETF (SPY)

We had great success with the SPY earlier this week, and we want to come back to it this morning in the wake of the markets getting crushed yesterday. With the amount of uncertainty and potential volatility out there, we want to set ourselves up to have an active idea no matter which way the winds blow.

Should the SPY fall below $276, we will target the SPY Weekly $277 & $276 Puts. If it pulls above $276 we will focus on the $276 and $277 Calls, so either way, we should be able to quickly identify the proper course once trading commences. .


Extended Watchlist: 
SBGL, PRPO, RH, HEAR, CEI, HMY, ACST, HSGX

Blue Horseshoe Stocks: Options Winners

Options Winners

Our acumen in identifying successful short-to-mid-term options plays has been at  a high level for years now, and this week has been no different than those that came before it.

It was on Tuesday morning that our report contained a pair of ideas relating to the TLRY and TSLA chains. With the help of a solid Wednesday session, all contracts involved have produced notable gain opportunities:

TLRY 09/21 $91-93 Calls
$91 Calls – Range: 6.43-16.00 – Max Gain: 149%
$92 Calls – Range: 5.51-15.40 – Max Gain: 179%
$93 Calls – Range: 5.23-15.48 – Max Gain: 196%

TSLA 10/06 $285-290 Calls
$285 Calls – Range: 12.26-21.17 – Max Gain: 73%
$287.50 Calls – Range: 12.02-19.39 – Max Gain: 61%
$290 Calls – Range: 10.50-18.92 – Max Gain: 80%

Additionally, we signaled the BHC Weekly $21-22.50 Calls in yesterday morning’s report, and the $22′s and the $22.50′s yielded the most positive single-session results. The $22′s ran from .76-2.00 for a gain of 163% while the $22.50′s traded up from a low of .40 to hit 1.19, which worked out to a move of 198%
______

FRESH IDEA:
KR Weekly $31-29 Puts


Extended Watchlist:
PDD, CARA, GNC, SLS, TKC, GERN, TLRD, PRPO

Blue Horseshoe Stocks: Options Review

Tiffany & Co. TIF – Options Recap
We wanted to take an opportunity to backtrack to our options idea from Wednesday, the TIF Weekly $114-117 Calls. We caught the stock on the heels of its earnings report, and the subsequent activity allowed for a good chance for us at the top of that range.

Our ideas got pushed so deep in the money, that the big winner turned out to be the 117′s. Those contracts started out on Wednesday from a low of 1.53, and as of yesterday had reached an impressive high of 8.24. That works out to a two-day swing of 439%


Footlocker, Inc. FL 

We’ve had some good luck with the FL options chain in the past, and we’re going to place some contracts on watch today in the wake of the company’s big profit and sales beat this morning. Q1 earnings blew people away today, and as a result the stock is up considerably.

With no weekly expiration contracts available, we’re going to go out to the FL 06/15 $52.50-55 Calls, for potential quick strike trades.


Extended Watchlist:
QUIK, CDTX, CLWT, AVGR, OHGI, AVGR, PRPO

Blue Horseshoe Stocks: VTVT Recap & More

vTv Therapeutics, Inc. VTVT

Our report yesterday morning included  a look at the VTVT chart, and establishing our interest in tracking it as a bottom play. Our timing in this really could not have been any better as the stock not only made it biggest single session move of the year, but also traded its highest volume.

VTVT ran from a low of .79 and reached as high as 1.67, a 53% intraday rip, and ended up closing at 1.19, filling a portion of the large gap which you can plainly see below. Based on the activity we’ve now witnessed, and the still-ripe look of the chart, we’re going to continue to keep a close watch over VTVT.


Van Eck Vectors Gold Miners ETF (GDX)

We also want to begin tracking a pair of options contracts in the GDX chain. Gold has been doing well and looks as if another solid day could be in the cards.

On that event, there should be some nice activity in the GDX Weekly $22.50 & $23 Calls, so we’ll be monitoring for that.



Tandem Diabetes Care, Inc. TNDM – Update

It was a week ago today that we were commenting on our coverage of TNDM in 2018. We caught this stock at a low of 2.14 earlier this year, and it has come a long way since then.

This week the stock has traded up to a high of 7.75, marking an increase of 262% since we began tracking it.


Extended Watchlist:
TEUM, ARQL, SPWR, PRPO, INPX, USLV, OAS

Blue Horseshoe Stocks: BABA Review & More

Alibaba Group Holding Ltd. BABA – Update

After noticing a strong double-bottom setup on the chart, we threw our hat in the ring with BABA yesterday morning by formulating an options idea to track during what we described as an overdue recovery.

The stock did exhibit the first signs of that recovery, thereby producing some nice single-session gain opportunities for ourselves and our readers. Our targeted options were the BABA 05/04 $180-187.50 Calls, and regardless of the strike price chosen within our designated range, notable able intraday profits were there for the taking.

$180 Calls – Range: 3.60-5.10  – Max Gain: 42%
$182.50 Calls – Range: 2.80-3.75 – Max Gain: 34%
$185 Calls – Range: 2.21-3.05 – Max Gain: 38%
$187.50 Calls – Range: 1.74-2.27 – Max Gain: 30%

There is, of course, plenty of time before these contracts expire, so we’ll continue monitor these ideas going forward in the event that BABA stock continues its rebounding ways. Further opportunities may arise and we’ll want to be ready.


Tandem Diabetes Care, Inc. TNDM – Update

We also wanted to update everyone on another longer term idea we formulated that has definitely worked out in our favor. We’ve had a number of stocks that we signaled our interest in earlier in 2018 slowly and steadily make monster moves for us, and TNDM is the latest one.

We initially slated this play for observation In mid-January, and after only a slight consolidation at the beginning of February, the stock established support at a low of 2.14, reversed, and began a really impressive bull run that was amplified by a significant degree yesterday. TNDM ran to a new high of 7.22. That works out to a 237% increase here in the early goings of the 2018 calendar year.


Extended Watchlist:
PVG, CRIS, EYEG, CBAY, PRPO